AstraZeneca Adressed Gilead Sciences to Discuss Potential Merger

Coinspeaker AstraZeneca Adressed Gilead Sciences to Discuss Potential MergerIf combined, AstraZeneca and Gilead Sciences would have a market capitalization of about $237 billion, exceeding Merck & Co and Pfizer worth $207 billion and $200 billion respectively.AstraZeneca Adressed Gilead Sciences to Discuss Potential Merger